Targeted delivery of RNA medicines to the brain. By silencing the genes that cause harm, we aim to preserve minds, protect memories, and enable our loved ones to live healthier, longer lives.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€32,000,000
Total raised
-
Valuation
27
Employees
2025
Founded
Latest round
Series A - February 9, 2026
Series A - €32,000,000
February 9, 2026
✓ verified by our desk
Open roles
Aerska is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile